Back
Endava PLC Vs. Cidara Therapeutics Industry Stock Comparison
Sell
21
DAVA
Endava PLC
Last Price:
$12.78
Seasonality Move:
2.09%
Buy
69
CDTX
Cidara Therapeutics
Last Price:
$63.37
Seasonality Move:
-6.02%
Sell
21
Endava PLC (DAVA)
is a Sell
Is Endava PLC a Buy, Sell or Hold?
-
The current Endava PLC [DAVA] share price is $13.55. The Score for DAVA is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
DAVA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
69
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $61.79. The Score for CDTX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DAVA Stock Price Chart
What is Endava PLC's stock price today?
-
The Endava PLC share price today is $13.55Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DAVA is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $61.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing selling pressure, which indicates risk of future bearish movement.
DAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.94 | Buy |
Relative Strength Index (14 RSI): | 40.83 | Sell |
Chaikin Money Flow: | -356282 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.72 - 15.22) | Sell |
Bollinger Bands (100): | (14.41 - 19.75) | Sell |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.74 | Buy |
Relative Strength Index (14 RSI): | 68.87 | Buy |
Chaikin Money Flow: | -161750 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.69 - 60.27) | Buy |
Bollinger Bands (100): | (15.59 - 45.13) | Buy |
DAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.35 | Sell |
20-day SMA: | 14.3 | Sell |
50-day SMA: | 14.9 | Sell |
200-day SMA: | 22.94 | Sell |
8-day EMA: | 5.43 | Buy |
20-day EMA: | 2.5 | Buy |
50-day EMA: | 1.06 | Buy |
200-day EMA: | 0.27 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.81 | Sell |
20-day SMA: | 55.87 | Buy |
50-day SMA: | 40.09 | Buy |
200-day SMA: | 24.77 | Buy |
8-day EMA: | 24.44 | Buy |
20-day EMA: | 11.22 | Buy |
50-day EMA: | 4.76 | Buy |
200-day EMA: | 1.22 | Buy |
Endava PLC Earnings Growth & DAVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.01 per share, an increase this year of $0.00 per share, and an increase next year of $0.05 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
Endava PLC Technical Analysis
Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |